Mechanisms of thyrotropin receptor-mediated phenotype variability deciphered by gene mutations and M453T-knockin

Kristiina Makkonen1,2, Meeri Jännäri1,2, Luís Crisóstomo2

  • 1Department of Clinical Sciences, Faculty of Medicine, and.

JCI Insight
|January 9, 2024
PubMed

Insights

Thyrotropin receptor (TSHR) variants influence thyroid disease risk and presentation. Genetic variations and iodine intake can modify TSHR-mediated disease phenotypes, necessitating personalized treatment approaches.

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Background:

  • Thyrotropin receptor (TSHR)-mediated diseases encompass a range of conditions, from congenital hypothyroidism to nonautoimmune hyperthyroidism (NAH).
  • The extrathyroidal functions of TSHR and the reasons for varied disease presentations remain poorly understood.
  • TSHR variations have been linked to metabolic and autoimmune thyroid conditions, but comprehensive analysis is lacking.

Purpose of the Study:

  • To identify and characterize TSHR variants and factors contributing to phenotypic variability in TSHR-mediated diseases.
  • To investigate the role of genetic and environmental factors in TSHR-related disorders.
  • To explore the mechanisms behind the diverse clinical manifestations of TSHR diseases.

Main Methods:

  • Analysis of TSHR variants in patient cohorts and the FinnGen database.
  • Characterization of novel TSHR constitutively active mutations (CAMs) in patients with NAH.
  • Generation and study of a TSHR M453T-knockin mouse model.

Main Results:

  • TSHR CAMs were identified in all NAH patients, including novel mutations in extracellular and transmembrane domains.
  • FinnGen database screening revealed rare functional TSHR variants and common noncoding SNPs associated with thyroid phenotypes.
  • No significant associations were found between TSHR variants and over 2,000 nonthyroid disease endpoints.
  • The mouse model demonstrated that TSHR phenotype depends on mutation signaling and is influenced by iodine intake.

Conclusions:

  • TSHR-mediated disease risk is influenced by coding and noncoding TSHR variants.
  • Altered TSHR signaling and dietary iodine intake are critical modifiers of disease phenotype.
  • These findings support the development of personalized treatment strategies for TSHR-related disorders.